Although miR-519a-3p and PARP1 move in opposite directions in terms of expression in the mentioned tumors compared to PDs, this does not mean that this model can be applied to all tumors or other neurodegenerative diseases. This evidence concerns the gene PARP1 and neurodegenerative disease.